Stockreport

Here’s What’s Behind The Hottest Battleground Stock in Cancer Treatment [The Motley Fool]

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF CEL-SCI(NYSEMKT:CVMshort-sellersMeanwhile, phase topline results from the company's only prominent candidate, Multikine (leukocyte injection for the treatment of cancer [Read more]